Thalidomide-NH-CH2-COOH
CAS No. 927670-97-1
Thalidomide-NH-CH2-COOH ( (2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)glycine; 2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]acetic acid )
产品货号. M28260 CAS No. 927670-97-1
Thalidomide-NH-CH2-COOH is a synthesized E3 ligase ligand-linker conjugate containing a Thalidomide-based cereblon ligand and a linker.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥300 | 有现货 |
|
10MG | ¥413 | 有现货 |
|
25MG | ¥648 | 有现货 |
|
50MG | ¥932 | 有现货 |
|
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Thalidomide-NH-CH2-COOH
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Thalidomide-NH-CH2-COOH is a synthesized E3 ligase ligand-linker conjugate containing a Thalidomide-based cereblon ligand and a linker.
-
产品描述Thalidomide-NH-CH2-COOH is a synthesized E3 ligase ligand-linker conjugate containing a Thalidomide-based cereblon ligand and a linker.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
同义词(2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)glycine; 2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]acetic acid
-
通路Others
-
靶点Other Targets
-
受体α7 nAChR
-
研究领域——
-
适应症——
化学信息
-
CAS Number927670-97-1
-
分子量331.3
-
分子式C15H13N3O6
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOC(CNc1cccc(C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Lagostena L, et al. The partial alpha7 nicotine acetylcholine receptor agonist S 24795 enhances long-term potentiation at CA3-CA1 synapses in the adult mouse hippocampus. Neuropharmacology. 2008 Mar;54(4):676-85.
产品手册
关联产品
-
Mitochondrial fusion...
Mitochondrial fusion promoter M1 is a mitochondrial dynamic modulator.
-
Arenobufagin
Arenobufagin is a natural bufadienolide from toad venom with potent antineoplastic activity against HCC HepG2 cells and corresponding multidrug-resistant HepG2/ADM cells.
-
NIC3
NIC3 is a selective nucleus accumbens-associated protein-1 (NAC1) inhibitor, with anti-cancer activity.